Article info

Original research
Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL

Authors

  • Tingting Zhang Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Hengqi Liu Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Lei Jiao Panovue Biological Technology Co., Ltd, Beijing, China PubMed articlesGoogle scholar articles
  • Zhenzhen Zhang Marvel Medical Laboratory, Tianjin Marvelbio Technology Co., Ltd, Tianjin, China PubMed articlesGoogle scholar articles
  • Jin He Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Lanfang Li Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Lihua Qiu Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Zhengzi Qian Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Shiyong Zhou Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Wenchen Gong Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China PubMed articlesGoogle scholar articles
  • Bin Meng Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China PubMed articlesGoogle scholar articles
  • Xiubao Ren Department of Immunology/Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China PubMed articlesGoogle scholar articles
  • Huilai Zhang Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  • Xianhuo Wang Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Xianhuo Wang; tjzlyy_xianhuow{at}163.com; Professor Huilai Zhang; zhlwgq{at}126.com
View Full Text

Citation

Zhang T, Liu H, Jiao L, et al
Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL

Publication history

  • Accepted March 14, 2022
  • First published April 1, 2022.
Online issue publication 
August 25, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.